Hyperfine (Nasdaq:HYPR) announced that it made the first commercial sales of its next-generation Swoop system powered by new ...

Nuwellis terminated its REVERSE‑HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart ...

Stereotaxis announced that it entered into definitive agreements with investors to sell approximately $12.5 million in common stock.

Exactech today announced it appointed Dr. Richard J. Friedman as chief medical officer, effective immediately.

NanoVibronix (Nasdaq:NAOV) today announced that it entered into a definitive agreement to sell up to $50 million in stock.

UroMems received FDA investigational device exemption (IDE) approval to begin a first-of-its-kind trial for its smart implant.

Xeltis today announced encouraging preliminary data for its Xabg coronary artery bypass conduit (CABG) device.

Saluda Medical today announced the full launch of its EVA next-generation sensing technology for its neuromodulation therapy.

Philips (NYSE: PHG) today announced the launch of its new electrocardiogram (ECG) AI marketplace for cardiac care teams.

Paradromics announced today that it selected a third investigator for its upcoming brain-computer interface (BCI) clinical ...

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).